Jafron Biomedical Co (SZSE:300529) Total Stockholders Equity : ¥3,229 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co Total Stockholders Equity?

Jafron Biomedical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥3,229 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Jafron Biomedical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥4.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Jafron Biomedical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.56.

Jafron Biomedical Co Total Stockholders Equity Historical Data

The historical data trend for Jafron Biomedical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jafron Biomedical Co Total Stockholders Equity Chart

Jafron Biomedical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,142.47

2,806.79

3,358.86

3,574.29

3,147.48

Jafron Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															3,772.40	3,237.78	3,109.71	3,147.48	3,229.06

Jafron Biomedical Co (SZSE:300529) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Jafron Biomedical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3229.06	-	0)	/	807.555
	=	4.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Jafron Biomedical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(549.275	+	1254.901)	/	3229.06
	=	0.56

Jafron Biomedical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jafron Biomedical Co (SZSE:300529) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085

Website

http://www.jafron.com

Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.

Executives

Li Feng	Director
He Xiao Lian	Executives
Dong Fan	Directors, Directors, and Executives
Ceng Kai	Directors, executives
Tang Xian Min	Directors, executives
Zhang Ming Yuan	Secretary Dong
Fang Li Hua	Supervisors
Zhang Guang Hai	Directors, executives
Li De Zhi	Executives
Lu Shao Zhang	Executives

Jafron Biomedical Co (SZSE:300529) Headlines

No Headlines